Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0000318306-15-000033
Filing Date
2015-06-19
Accepted
2015-06-19 16:44:29
Documents
1
Period of Report
2015-05-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4/A  
1 PRIMARY DOCUMENT primary_doc.xml 4/A 5636
  Complete submission text file 0000318306-15-000033.txt   7553
Mailing Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219
Business Address 3333 LEE PARKWAY SUITE 600 DALLAS TX 75219 2149055100
ABEONA THERAPEUTICS INC. (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SCO FINANCIAL GROUP LLC 1285 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK NY 10019
Business Address C/O SCO FINANCIAL GROUP LLC 1285 AVENUE OF THE AMERICAS 35TH FLOOR NEW YORK NY 10019 212-554-4158
Jeffrey B Davis (Reporting) CIK: 0001349083 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-15771 | Film No.: 15942875